本年度信息
国药控股(01099)发布的最新财报显示，2025年度公司营收为748.93亿元，同比下降2.35%。同期，经调整后净利润为5.07亿元，同比增长25.64%。经营利润为12.49亿元，经营利润率约为1.67%，相比上年同期略有提升。
经营活动产生的现金流量净额为7.39亿元，去年同期为-13.56亿元。本期末，公司总资产达573.02亿元，同比下降7.07%；归属于母公司所有者权益合计为83.00亿元，同比增长5.27%。
本年度信息
国药控股(01099)发布的最新财报显示，2025年度公司营收为748.93亿元，同比下降2.35%。同期，经调整后净利润为5.07亿元，同比增长25.64%。经营利润为12.49亿元，经营利润率约为1.67%，相比上年同期略有提升。
经营活动产生的现金流量净额为7.39亿元，去年同期为-13.56亿元。本期末，公司总资产达573.02亿元，同比下降7.07%；归属于母公司所有者权益合计为83.00亿元，同比增长5.27%。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.